Impaired NAD+ Metabolism in Neuronal Dysfunction in Critical Conditions

Impaired NAD+ Metabolism in Neuronal Dysfunction in Critical Conditions

The present views of the pathogenesis of neuronal dysfunction in critical conditions are analyzed, by taking into account of impairments of cellular NAD+ metabolism, the activity of NAD+-converting enzymes, including ADP-ribosyl cyclase/CD38, the possibilities of developing new neuroprotective strat...

Full description

Bibliographic Details
Main Authors:	A. V Salmina, A. A. Fursov, S. V Mikhutkina, S. V. Shakhmayeva, N. S. Mantorova
Format:	Article
Language:	English
Published:	Federal Research and Clinical Center of Intensive Care Medicine and Rehabilitology, Moscow, Russia 2008-02-01
Series:	Общая реаниматология
Online Access:	https://www.reanimatology.com/rmt/article/view/829

Similar Items

Development of Systemic Inflammatory Reaction after Aortocoronary Bypass Surgery: New Aspects
by: V. V. Moroz, et al.
Published: (2008-12-01)

Neuron-astroglial interactions in dysregulation of energy metabolism in perinatal ischemic brain damage
by: A. B. Salmina, et al.
Published: (2017-02-01)

Pathogenesis of a Systemic Inflammatory Reaction: New Aspects
by: AA. Fursov, et al.
Published: (2008-04-01)

Impaired Iron Metabolism in the Pathogenesis of Critical Conditions (an Experimental Study)
by: Yu. P. Orlov, et al.
Published: (2011-10-01)

Laser-induced autofluorescence for assessment of methabolism and hemodynamic characteristics of the brain
by: A. B. Salmina, et al.
Published: (2017-02-01)

Prevention of Postischemic Neurological Deficit by Modulating the Cerebral Cell Expression of ADP-Ribosyl Cyclase (Experimental Study)
by: A. A. Fursov, et al.
Published: (2007-12-01)

NAD<sup>+</sup> Metabolism and Diseases with Motor Dysfunction
by: Samuel Lundt, et al.
Published: (2021-11-01)

Role of Nitric Oxide in Neuronal Damages in Critical Conditions
by: A. V. Kiseleva, et al.
Published: (2009-10-01)

Inhibition of the NAD salvage pathway in schistosomes impairs metabolism, reproduction, and parasite survival.
by: Michael D Schultz, et al.
Published: (2020-05-01)

Instability in NAD+ metabolism leads to impaired cardiac mitochondrial function and communication
by: Knut H Lauritzen, et al.
Published: (2021-08-01)

Metabolic Desynchronization in Critical Conditions: Experimental Study
by: G. V. Livanov, et al.
Published: (2006-02-01)

Mitochondrial Impairment May Increase Cellular NAD(P)H: Resazurin Oxidoreductase Activity, Perturbing the NAD(P)H-Based Viability Assays
by: Vasily A. Aleshin, et al.
Published: (2015-08-01)

Rising of intracellular NAD+ level and oppositely directed changes in CD38 expression in hippocampal cells in experimental Alzheimer’s disease
by: A. A. Semenova, et al.
Published: (2021-10-01)

NAD-Linked Metabolism and Intervention in Short Telomere Syndromes and Murine Models of Telomere Dysfunction
by: Amanda J Stock, et al.
Published: (2021-10-01)

Metabolically distinct roles of NAD synthetase and NAD kinase define the essentiality of NAD and NADP in Mycobacterium tuberculosis
by: Ritu Sharma, et al.
Published: (2023-08-01)

NAD+ Metabolism, Metabolic Stress, and Infection
by: Benjamin Groth, et al.
Published: (2021-05-01)

KL1333, a Novel NAD+ Modulator, Improves Energy Metabolism and Mitochondrial Dysfunction in MELAS Fibroblasts
by: Kang-Sik Seo, et al.
Published: (2018-07-01)

NAD Metabolism in Cancer Therapeutics
by: Keisuke Yaku, et al.
Published: (2018-12-01)

Metabolic and Bactericidal Effects of Targeted Suppression of NadD and NadE Enzymes in Mycobacteria
by: Irina A. Rodionova, et al.
Published: (2014-02-01)

Impact of Iron Metabolic Disturbances on Hemostasis in Critical Conditions
by: Yu. P. Orlov, et al.
Published: (2007-04-01)

Integration of Metabolism in Man and His Microbiome in Critical Conditions
by: N. V. Beloborodova
Published: (2012-08-01)

Impact of NAD+ metabolism on ovarian aging
by: Jinghui Liang, et al.
Published: (2023-12-01)

NAD depletion mediates cytotoxicity in human neurons with autophagy deficiency
by: Congxin Sun, et al.
Published: (2023-05-01)

Structural modeling of NAD+ binding modes to PARP-1
by: N. V. Ivanisenko, et al.
Published: (2017-02-01)

CD38-Induced Metabolic Dysfunction Primes Multiple Myeloma Cells for NAD<sup>+</sup>-Lowering Agents
by: Pamela Becherini, et al.
Published: (2023-02-01)

RATIONALE FOR PREVENTION OF CARDIO-CEREBRAL COMPLICATIONS IN THE METABOLIC SYNDROME BASED ON MATHEMATICAL FORECASTING TECHNIQUES
by: S. V. Chernavskii, et al.
Published: (2014-07-01)

RATIONALE FOR PREVENTION OF CARDIO-CEREBRAL COMPLICATIONS IN THE METABOLIC SYNDROME BASED ON MATHEMATICAL FORECASTING TECHNIQUES
by: S. V. Chernavskii, et al.
Published: (2014-07-01)

Epithelial NAD+ depletion drives mitochondrial dysfunction and contributes to intestinal inflammation
by: Elizabeth A. Novak, et al.
Published: (2023-09-01)

Ozone Exposure Induces Metabolic Disorders and NAD+ Depletion Through PARP1 Activation in Spinal Cord Neurons
by: Shulin Ma, et al.
Published: (2020-12-01)

The Impair Iron Metabolism in Acute Pancreatitis
by: Yu. P. Orlov, et al.
Published: (2010-10-01)

Changes in NAD/ADP-ribose metabolism in rectal cancer
by: L. Yalcintepe, et al.
Published: (2005-03-01)

Pathogenetic Role of Cholesterol and Triglyceride Metabolic Disturbances in the Development of Critical Conditions
by: S. A. Perepelitsa, et al.
Published: (2015-10-01)

NAD depletion mediates cytotoxicity in human neurons with autophagy deficiency
Published: (2024)

Impaired nicotinamide adenine dinucleotide (NAD+) metabolism in diabetes and diabetic tissues: Implications for nicotinamide‐related compound treatment
by: Lan Fan, et al.
Published: (2020-11-01)

Role of bioactive lipids in metabolism of obese patients and prospects for their use in the postoperative period
by: A. B. Fursov, et al.
Published: (2021-06-01)

Role of NAD+ in regulating cellular and metabolic signaling pathways
by: Sara Amjad, et al.
Published: (2021-07-01)

PARPs, PAR and NAD Metabolism and Their Inhibitors in Cancer
by: Nicola Curtin, et al.
Published: (2020-11-01)

NAD+ metabolism-based immunoregulation and therapeutic potential
by: Jiankai Fang, et al.
Published: (2023-05-01)

NAD+ metabolism controls inflammation during senescence
by: Timothy Nacarelli, et al.
Published: (2019-07-01)

NAD+ metabolism, stemness, the immune response, and cancer
by: Lola E. Navas, et al.
Published: (2021-01-01)